logo
My state is conquering the opioid crisis. Other states need to do the same

My state is conquering the opioid crisis. Other states need to do the same

Fox News24-02-2025
Most people understand that our country is facing a crisis of opioid addiction and deaths. To combat this, you need proven solutions and resources. Yet, a lot of the money that is supposed to be spent combating that crisis is instead sitting idle in government bank accounts.
This isn't taxpayer money; it's part of a legal settlement that companies who were accused of recklessly fueling the opioid crisis agreed to pay to provide some relief to those communities ravaged by addiction. In late January, Purdue Pharma and the Sackler family agreed to increase the amount they're paying to $7.4 billion. But many states and localities are sitting on millions that they seem oddly hesitant to spend.
Every state has money to distribute. Since 2021, companies involved in manufacturing and distributing legal opioids, along with some pharmacies, have agreed to pay approximately $50 billion in total settlements.
I was governor for eight years in New Hampshire, and the smartest thing to combat this crisis was to not hesitate. We don't have all the answers regarding addiction, but we've made progress with the rest of the country has stalled.
When I took office in 2017, we had the second-highest opioid overdose death rate in the country. Since that time, our overdose death rate has dropped over 30%, while the national average continued to climb. We now rank twenty-second, and we have the lowest overdose death rate in New England. (Recently, for the first time in years, the national opioid death rate has begun to decline.)
When I took office, heroin and opioid pills were cheap; those who tried to recover couldn't get help. Waiting lists for treatment were more than six weeks long. I went right to the people on the front lines of the crisis to find the answers. They knew that addicts could best be reached right after an overdose. If there was no readily available treatment, their patterns would just continue.
Two essential changes helped us lower our rate. We changed our approach to treatment beginning in 2019 through what we call The Doorway program. This new system design was founded on one critical thesis, rural access to care was the greatest barrier to functional addicts. Addiction rates were far greater in rural areas than anything seen in our small cities, but all the resources and treatment programs were located in the cities and out of reach of the average citizen.
With nine regional Doorway locations, help is always within an hour's reach for anyone in the state. The program is funded primarily through the federal State Opioid Response (SOR) grant, and has let us expand the use of medicine, peer support and techniques for prevention.
In the first six months, more than 3,200 people sought help through the Doorway, and monthly client numbers continue to rise. By destigmatizing addiction and simplifying the process for seeking help, the program helped cut the numbers of overdoses and deaths.
Police officers and treatment experts can't be everywhere all the time, so we also invested over $3 million to put naloxone, which can reverse the effects of opioids in someone who has overdosed, just about everywhere we could. Early in my administration, we decided that if our streets were to be flooded with deadly drugs like fentanyl, we needed to flood them with life-saving opioid reversal medicines.
We then changed our laws to ensure that all first responders, whether they be fire or police, could administer life-saving naloxone, without fear of unnecessary training or liability concerns.
When I took office in 2017, we had the second-highest opioid overdose death rate in the country. Since that time, our overdose death rate has dropped over 30%, while the national average continued to climb.
New Hampshire also became the first state to install NaloxBoxes in public spaces, for first responders, but also anyone who might overdose. Our Good Samaritan laws also allowed numerous instances where naloxone was administered by bystanders before emergency services arrived and directly saved lives.
Ken Trogdon, whose nonprofit HarborPath works with states and organizations to distribute naloxone where it's most needed, emphasizes its importance. "As a nation, we need to get this life-saving drug within arm's length of everyone who might potentially need it. Unfortunately, that means we basically need it everywhere," he says.
To date, states have received approximately $6 billion of the $50 billion they are slated to receive from opioid settlements. Yet reports suggest that as much as a third or even half of these funds remain unspent. That's not good enough. I implore governors and mayors across the country to not hesitate, think creatively, and find results-driven solutions similar to what we put here in New Hampshire to increase access to life-saving care. The strategies we've implemented are working, and no one across America can afford for this fight to be halfhearted.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it
A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

Washington Post

time18-06-2025

  • Washington Post

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

All 50 U.S. states have agreed to the OxyContin maker Purdue Pharma 's latest plan to settle thousands of lawsuits over the toll of opioids . A judge on Wednesday is being asked to clear the way for local governments and individual victims to vote on it. Government entities, emergency room doctors, insurers, families of children born into withdrawal from the powerful prescription painkiller, individual victims and their families and others would have until Sept. 30 to vote on whether to accept the deal, which calls for members of the Sackler family who own the company to pay up to $7 billion over 15 years.

Utah to sign $57 million settlement with Purdue Pharma over its role in opioid crisis
Utah to sign $57 million settlement with Purdue Pharma over its role in opioid crisis

Yahoo

time18-06-2025

  • Yahoo

Utah to sign $57 million settlement with Purdue Pharma over its role in opioid crisis

Utah Attorney General Derek Brown talks to reporters during his first press conference at the Utah State Capitol Building on Thursday, Jan. 9, 2025. (Kyle Dunphey/Utah News Dispatch) It's almost official. Utah is close to signing a settlement to receive $57 million in an agreement with the Sackler family and its former pharmaceutical company Purdue Pharma, the manufacturers of OxyContin, over their role in the country's opioid epidemic. In total, all 50 states, the District of Columbia and U.S. territories are soon to settle for $7.4 billion, according to the Utah Attorney General's Office, which described the agreement as 'monumental' and 'a critical step towards accountability.' In Utah the money will be used for efforts to combat the effects of the crisis in communities across the state. That's in addition to the $540 million the state is slated to receive from other settlements, with $275 million designated for the state and $265 million for counties. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX 'Utah families deserve this resolution after Purdue Pharma and the Sackler family recklessly harmed our communities, and contributed to the opioid epidemic,' Utah Attorney General Derek Brown said in a statement. 'I will continue to use all the tools I have available, including litigation and prosecution, to protect Utahns in the future from these deadly drugs.' Under the Sacklers' management, Purdue Pharma manufactured opioids like OxyContin, marketing it as a safe despite their knowledge of its highly addictive nature, the AG's office wrote in a release. The campaign led to a surge in opioid prescriptions in the state. Utah expected to join at least a dozen states in Purdue Pharma settlement The Utah Division of Consumer Protection has pursued an administrative action against the company, Richard Sackler and Kathe Sackler since 2019 with allegations that they participated in 'deceptive' practices, provided nearly $200,000 in gifts and payments to prescribers in Utah between 2013 and 2017, and employed 186 sales representatives in the state who conducted in-person marketing visits to 5,000 prescribers — all practices that intensified the opioid crisis here, the release says. The settlement establishes that the Sackler family will pay $6.5 billion in the next 15 years 'coming from Purdue Pharma upon its emergence from bankruptcy protection.' Additionally, the family won't be able to control the pharmaceutical company, the agreement says. It also restricts Purdue Pharma's opioid sales in the country. Between 2002 and 2015, opioid prescriptions surged by over one million, according to the AG's office. Between 2014 and 2019, prescription opioids caused 1,611 deaths in the state. The state has also reached settlements with major corporations including Walmart, Walgreens, Kroger, CVS, Publicis Health, McKinsey, Cardinal, Johnson & Johnson, Allergan, Teva, McKesson, AmerisourceBergen and Mallinckrodt. 'Purdue Pharma and the Sackler family caused immense harm and innumerable lives lost through their deceptive marketing and greed,' Margaret Woolley Busse, executive director of the Utah Department of Commerce said in a statement. 'Utah never stopped its work to hold Purdue and the Sacklers accountable for what they have done and the devastation they have caused.' SUPPORT: YOU MAKE OUR WORK POSSIBLE

More states back $7.4 billion Purdue Pharma opioid settlement
More states back $7.4 billion Purdue Pharma opioid settlement

Yahoo

time17-06-2025

  • Yahoo

More states back $7.4 billion Purdue Pharma opioid settlement

Fifty-five attorneys general around the country have now signed on to a $7.4 billion settlement with drugmaker Purdue Pharma and its owners, the Sackler family, over the opioid crisis, officials said. Fifteen states initially agreed to the settlement in January. Since then, an additional 34 states, five territories and Washington, D.C., joined the settlement, according to details released Monday by attorneys general involved in the case. Oklahoma reached a separate $270 million settlement in 2019. If the settlement is approved in court, it would end the Sacklers' control of Purdue, maker of the addictive painkiller OxyContin, and block the family from selling opioids in the U.S., officials said. "For decades, the Sacklers put profits over people, and played a leading role in fueling the epidemic of opioid addictions and overdoses," New York Attorney General Letitia James said in a statement. "While no amount of money can fully heal the destruction they caused, these funds will save lives and help our communities fight back against the opioid crisis." The money will be paid out over the course of 15 years, but officials said over half of the funds will be distributed during the first few years. The Sacklers will make an initial payment of $1.5 billion and Purdue will pay about $900 million. Then the Sacklers will pay $500 million after a year, an additional $500 million after two years and $400 million more after three years. Not all states will receive the same amount. California expected to receive as much as $440 million. Colorado estimated it would collect around $75 million. New Jersey estimated it would get up to $124.5 million. New York expected to receive up to $250 million. In a statement to CBS News, Purdue said the settlement funds will be used to "compensate victims, abate the opioid crisis, and deliver opioid use disorder and overdose rescue medicines that will save American lives." "We appreciate the extraordinarily hard work of the state attorneys general and our other creditors in getting us to this point," the company said. The deal leaves Purdue in bankruptcy with oversight by a monitor and prevents the company from lobbying or marketing opioids. The states involved in the settlement will appoint a board of trustees to oversee the company and determine its future. The previous Purdue bankruptcy settlement was struck down by the U.S. Supreme Court last year. In a 5-4 decision, the justices said that Sackler family members could not be shielded from liability for civil claims related to the opioid epidemic. The original settlement would have required the Sacklers and Purdue to pay over $4.5 billion. What's next for Minnesota lawmaker shootings suspect? Trump says he wants a "real end" to Iran's nuclear program How to spot the early signs of cognitive decline

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store